Drug maker Pfizer says it's planning to start testing its COVID-19 vaccine on children as young as 12. This will be the first coronavirus vaccine trial to include children in the United States. The ...
Albert Bourla, who four years ago led Pfizer through its scientific and financial triumph during the COVID-19 pandemic, is suddenly facing a new challenge from a large shareholder frustrated over the ...
A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...
Final analysis: Pfizer's COVID-19 vaccine 95% effective, company to seek authorization within 'days'
A final analysis of a COVID-19 vaccine candidate produced by Pfizer and BioNTech shows that the drug is 95% effective in preventing the coronavirus, and the companies say they hope to apply for ...
Newly released data from Pfizer/BioNTech’s ongoing study of their COVID-19 vaccine suggests it is effective at preventing serious symptoms and death at least six months after vaccination. The ...
SANTIAGO, Nov 27 (Reuters) - Peru has secured enough coronavirus vaccine to give nearly three-quarters of its population at least one dose when the immunization is available, a hopeful development for ...
Pfizer and BioNTech said Wednesday that initial lab tests show that the omicron variant partly escapes protection offered by the companies' two-dose regimen of their COVID-19 vaccine. However, those ...
KALAMAZOO, Mich. -- Even though U.S. health officials authorized the emergency use of Pfizer's COVID-19 vaccine, getting the pandemic under control will take time and effort. One of the biggest steps ...
Pfizer says kid-size doses of its COVID-19 vaccine are safe and nearly 91% effective at preventing infections in elementary school children. Details of the study were posted online Friday. FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback